The antiphospholipid syndrome is characterized by venous or arterial thrombosis and/or
recurrent fetal loss in the presence of circulating antiphospholipid antibodies. These …

Background: Annexin A5 is thought to have a role in the pathophysiology of the
antiphospholipid syndrome (APS)—a syndrome characterised by recurrent thrombosis and …

Antiphospholipid-mediated endothelium perturbation plays a role in antiphospholipid
syndrome (APS)-associated vasculopathy. Antiphospholipid antibodies activate …

The antiphospholipid (aPL) antibody syndrome is an autoimmune condition in which
vascular thrombosis and/or recurrent pregnancy losses occur in patients with laboratory …

Objectives Antiphospholipid syndrome (APS) is associated with neurological manifestations
and one of the novel autoantigens associated with this disease is Annexin A2 (ANXA2). In …

Though many neurological deficits have been described in the antiphospholipid syndrome
(APS), only stroke is well establishedand accepted as a diagnosticcriterion in this disease …

Antiphospholipid syndrome is a systemic autoimmune disease associated with thrombosis
and recurrent fetal loss in the setting of detectable antiphospholipid (aPL) antibodies. The …

In this study we analyzed whether anti-β2-GPI antibodies from patients with APS induce the
endothelial cell expression of Tissue Factor (TF) by a LRP6 signal transduction pathway …

Antiphospholipid antibodies (aPL), the majority of which are directed against β2-
glycoprotein I (β2GPI), are associated with an increased incidence of venous and arterial …

Antiphospholipid antibodies are a heterogeneous group of autoantibodies associated with
the hypercoagulable state affecting all vascular districts with thrombosis named …